AI research center opens at Canadian medical school

North of the border, two grants of $200,000 are on offer for researchers innovating transformative ways to apply AI in healthcare—and they’re only one part of an ambitious academic endeavor to expand medical AI.

The University of Toronto announced the undertaking Dec. 9. The work as a whole is the launch of the school’s new Temerty Centre for AI Research and Education in Medicine, or T-CAIREM.

The school says the center hit the ground running, as around 400 researchers pre-joined this past summer.

“Toronto is uniquely positioned to lead globally in artificial intelligence in healthcare,” says Muhammad Mamdani, PharmD, MPH, the center’s inaugural director. “Our expertise in medicine and allied health sciences, computer science, statistics, mathematics and engineering is among the best in the world.”

Full announcement here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.